Riskpilot← Back to searchSign inGet full accessLüning Medical AB
ABIn liquidationOrg 5567362610General medical practice activities · NACE 8621Est. 20071 employees
Revenue 2023
SEK 0
EBITDA margin
—
-24% vs 2022
Equity ratio
92.3%
Financial strength
Net profit 2023
SEK 144
+102% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -147K | -24% |
| Net profit | SEK 144 | +102% |
| Total assets | SEK 404K | -24% |
| Equity | SEK 373K | +0% |
| Employees | 1 | — |
Legal name
Lüning Medical AB
Org number
5567362610
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 augusti 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Aktiebolaget ska vara att bedriva medicinsk praktik, mottagningsverksamhet och konsultverksamhet, samt köp och försäljning av medicinska produkter och rehabiliteringsprodukter samt förvalta värdepapper, fastigheter samt idka därtill förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 15 | 10 | 4 | 0 | 0 |
| Staff expenses | — | — | — | −110 | −110 |
| EBITDA | −137 | −139 | −185 | −118 | −147 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −137 | −139 | −185 | −118 | −147 |
| Net financials | 5 | 5 | 4 | 5 | 10 |
| Profit before tax | −7 | −7 | 4 | −8 | 3 |
| Tax | −0 | −0 | −3 | −0 | −3 |
| Net profit | −7 | −7 | 1 | −8 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 988 | 811 | 651 | 531 | 404 |
| Equity | 386 | 380 | 380 | 373 | 373 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 44 | 1 | 25 | 19 | 31 |
| Total debt | 44 | 1 | 25 | 19 | 31 |
EBITDA margin
-14700300.0%
This company
15.8%
Market median
-93039973% vs market
20192023
Equity ratio
92.3%
This company
38.2%
Market median
+142% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
14400.0%
This company
8.1%
Market median
+177678% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LB External Signatory | External Signatory | 2024 |
IM External Signatory | External Signatory | 2024 |
BJ External Signatory | External Signatory | 2024 |
UM Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lüning Reumatolog AB
Lüning Medical AB Board members of Lüning Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Ulrika Margareta Ahlholm | Liquidator | 0 companies |
| Lisa Kristina Lüning Rusén | Deputy Board Member | 0 companies |
| Karl Johann Telemaque Lüning | Board of Directors | 0 companies |